BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16643847)

  • 61. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria.
    Lepenies B; Pfeffer K; Hurchla MA; Murphy TL; Murphy KM; Oetzel J; Fleischer B; Jacobs T
    J Immunol; 2007 Sep; 179(6):4093-100. PubMed ID: 17785848
    [TBL] [Abstract][Full Text] [Related]  

  • 62. B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation.
    Zhang Z; Xu X; Lu J; Zhang S; Gu L; Fu J; Jin L; Li H; Zhao M; Zhang J; Wu H; Su L; Fu YX; Wang FS
    J Infect Dis; 2011 Jun; 203(11):1668-78. PubMed ID: 21592997
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of B and T lymphocyte attenuator, retinoid-related orphan receptor gamma-isoform-t and interleukin 7 in psoriasis vulgaris.
    Youssef RM; El-Ramly AZ; Hussien MF; Shoukry NM; Amr K
    Australas J Dermatol; 2019 May; 60(2):e132-e137. PubMed ID: 30671936
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multifaceted Role of BTLA in the Control of CD8
    Ritthipichai K; Haymaker CL; Martinez M; Aschenbrenner A; Yi X; Zhang M; Kale C; Vence LM; Roszik J; Hailemichael Y; Overwijk WW; Varadarajan N; Nurieva R; Radvanyi LG; Hwu P; Bernatchez C
    Clin Cancer Res; 2017 Oct; 23(20):6151-6164. PubMed ID: 28754817
    [No Abstract]   [Full Text] [Related]  

  • 65. Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus.
    Zhang M; Howard K; Winters A; Steavenson S; Anderson S; Smelt S; Doellgast G; Sheelo C; Stevens J; Kim H; Hamburger A; Sein A; Caughey DJ; Lee F; Hsu H; Siu G; Byrne FR
    Clin Exp Immunol; 2011 Jan; 163(1):77-87. PubMed ID: 21078085
    [TBL] [Abstract][Full Text] [Related]  

  • 66. BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.
    Derré L; Rivals JP; Jandus C; Pastor S; Rimoldi D; Romero P; Michielin O; Olive D; Speiser DE
    J Clin Invest; 2010 Jan; 120(1):157-67. PubMed ID: 20038811
    [TBL] [Abstract][Full Text] [Related]  

  • 67. BTLA, a new inhibitory B7 family receptor with a TNFR family ligand.
    Zeng C; Wu T; Zhen Y; Xia XP; Zhao Y
    Cell Mol Immunol; 2005 Dec; 2(6):427-32. PubMed ID: 16426492
    [TBL] [Abstract][Full Text] [Related]  

  • 68. B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation.
    Krieg C; Boyman O; Fu YX; Kaye J
    Nat Immunol; 2007 Feb; 8(2):162-71. PubMed ID: 17206146
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells.
    Werner K; Dolff S; Dai Y; Ma X; Brinkhoff A; Korth J; Gäckler A; Rohn H; Sun M; Cohen Tervaert JW; van Paassen P; Kribben A; Witzke O; Wilde B
    Front Immunol; 2019; 10():2843. PubMed ID: 31921121
    [No Abstract]   [Full Text] [Related]  

  • 70. [BTLA Characterization and its association with disease progression in patients with chronic HIV-1 infection.].
    Xu XS; Zhang Z; Gu LL; Wang FS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Dec; 25(12):1158-60. PubMed ID: 19961807
    [TBL] [Abstract][Full Text] [Related]  

  • 71. B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function.
    Cai G; Nie X; Li L; Hu L; Wu B; Lin J; Jiang C; Wang H; Wang X; Shen Q
    J Gastroenterol; 2013 Dec; 48(12):1362-72. PubMed ID: 23532637
    [TBL] [Abstract][Full Text] [Related]  

  • 72. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.
    Sordo-Bahamonde C; Lorenzo-Herrero S; Martínez-Pérez A; Gonzalez-Rodriguez AP; Payer ÁR; González-García E; Aguilar-García C; González-Rodríguez S; López-Soto A; García-Torre A; Gonzalez S
    Cancer Immunol Immunother; 2023 Jul; 72(7):2529-2539. PubMed ID: 37041226
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression and clinical significance of B and T lymphocyte attenuator on CD4
    Shen X; Zhang J; Tang P; Song H; Liu X; Huang Z; Zhang X; Wang X; Wu M
    Indian J Pathol Microbiol; 2019; 62(2):232-238. PubMed ID: 30971546
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Distinct Changes of BTLA and HVEM Expressions in Circulating CD4
    Liu J; Li J; He M; Zhang GL; Zhao Q
    J Immunol Res; 2018; 2018():4561571. PubMed ID: 30116751
    [TBL] [Abstract][Full Text] [Related]  

  • 75. THEMIS promotes T cell development and maintenance by rising the signaling threshold of the inhibitory receptor BTLA.
    Mélique S; Vadel A; Rouquié N; Yang C; Bories C; Cotineau C; Saoudi A; Fazilleau N; Lesourne R
    Proc Natl Acad Sci U S A; 2024 May; 121(20):e2318773121. PubMed ID: 38713628
    [TBL] [Abstract][Full Text] [Related]  

  • 76. B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.
    Piancone F; Saresella M; Marventano I; La Rosa F; Zoppis M; Agostini S; Longhi R; Caputo D; Mendozzi L; Rovaris M; Clerici M
    Sci Rep; 2016 Jul; 6():29699. PubMed ID: 27412504
    [TBL] [Abstract][Full Text] [Related]  

  • 77. BTLA-expressing CD11c antigen presenting cells in patients with active tuberculosis exhibit low capacity to stimulate T cell proliferation.
    Wang WD; Gao YC; Lu YB; Zhang JA; Liu GB; Kong B; Xiang WY; Dai YC; Yu SY; Jia Y; Fu XX; Yi LL; Zheng BY; Chen ZW; Zhong J; Xu JF
    Cell Immunol; 2017 Jan; 311():28-35. PubMed ID: 27717503
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA.
    Flynn R; Hutchinson T; Murphy KM; Ware CF; Croft M; Salek-Ardakani S
    PLoS One; 2013; 8(10):e77991. PubMed ID: 24205056
    [TBL] [Abstract][Full Text] [Related]  

  • 79. B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells.
    Hurchla MA; Sedy JR; Gavrieli M; Drake CG; Murphy TL; Murphy KM
    J Immunol; 2005 Mar; 174(6):3377-85. PubMed ID: 15749870
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of clostridium butyricum and bifidobacterium on BTLA expression on CD4
    Zhang SF; Tang ZS; Tong L; Tao XX; Suo QF; Xu XM
    Microb Pathog; 2016 Nov; 100():112-118. PubMed ID: 27622346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.